S245: RUXOLITINIB IN PEDIATRIC PATIENTS WITH TREATMENT-NAIVE OR STEROID-REFRACTORY CHRONIC GRAFT VERSUS HOST DISEASE: PRIMARY FINDINGS FROM THE PHASE II REACH5 STUDY

• Franco Locatelli,
• Bulent Antmen,
• Hyoung Jin Kang,
• Katsuyoshi Koh,
• Yoshiyuki Takahashi,
• Alphan Kupesiz,
• Maria Gabriela Matos,
• Donna Wall,
• Sunil Bhat,
• Ho Joon Im,
• Tayfun Gungor,
• Meng-Yao Lu,
• Tommaso Stefanelli,
• Christine Rosko,
• Annie St. Pierre,
• Karin Burock,
• Cristina Diaz-De-Heredia

Affiliations

Franco Locatelli

1 Dept of Pediatric Hematology/Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children’s Hospital, Catholic University of the Sacred Heart, Rome, Italy

Bulent Antmen

2 Division of Pediatric Hematology and Oncology and Stem Cell Transplantation, Department of Pediatrics, Acibadem Adana Hospital, Adana, Turkey

Hyoung Jin Kang

3 Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul National University Children’s Hospital, Seoul, Korea, Rep. of South

Katsuyoshi Koh

4 Department of Hematology/Oncology, Saitama Children’s Medical Center, Saitama, Japan

Yoshiyuki Takahashi

5 Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan

Alphan Kupesiz

6 Pediatric Hematology Oncology, Akdeniz University School of Medicine, Antalya, Turkey

Maria Gabriela Matos

7 GRAACC, Sao Paulo, Brazil

Donna Wall

8 The Hospital for Sick Children, The University of Toronto, Toronto, Canada

Sunil Bhat

9 Mazumdar-Shaw Medical Center, Narayana Health City, Bangalore, India

Ho Joon Im

10 Division of Pediatric Hematology/Oncology, Department of Pediatrics, Asan Medical Center Children’s Hospital, University of Ulsan College of Medicine, Seoul, Korea, Rep. of South

Tayfun Gungor

11 Department of Hematology/Oncology/Immunology, Gene Therapy, and Stem Cell Transplantation, University Children’s Hospital Zurich-Eleonore Foundation & Children’s Research Center, Zürich, Switzerland

Meng-Yao Lu

12 Department of Pediatrics, National Taiwan University Children’s Hospital, Taipei, Taiwan

Tommaso Stefanelli

13 Novartis Pharma AG, Basel, Switzerland

Christine Rosko

14 Novartis Pharmaceuticals Corporation, East Hanover, United States

Annie St. Pierre

13 Novartis Pharma AG, Basel, Switzerland

Karin Burock

13 Novartis Pharma AG, Basel, Switzerland

Cristina Diaz-De-Heredia

15 Division of Pediatric Hematology and Oncology and Stem Cell Transplantation, Hospital Universitari Vall d’Hebron, Vall d’Hebron Institut de Recerca, Barcelona, Spain